Team Sky keen for a select committee report to be scrutinised

Team Sky say they would welcome a UCI inquiry into the findings of a Digital, Culture, Media and Sport (DCMS) select committee.

The committee claimed that Team Sky and 2012 Tour de France winning rider Sir Bradley Wiggins used the drug Triamcinolone, which is only allowed for medical purposes, as a means of enhancing performance.

French head of the UCI David Lappartient has said the governing body's independent anti-doping unit, the CADF, should follow up the committee's report to see if there has been a violation of anti-doping rules.

Team Sky subsequently issued a statement which read: "Team Sky is happy to co-operate with any investigation by the UCI and we would welcome further scrutiny of the select committee's report.

"While we have acknowledged past failings, we strongly deny the very serious new allegations about the use of medication to enhance performance, as does Bradley Wiggins.

"Furthermore, we are concerned that the committee presented these unsubstantiated allegations without providing evidence to support them, which is fundamentally unfair to the team and it's riders.

"We welcome any review by the UCI which can help establish the nature of the evidence relied on by the committee in coming to its conclusions."

Team Sky and Wiggins have strongly denied the DCMS report's claims and have said any medication they have used has been for legitimate reasons and within UCI and World Anti-Doping Agency rules.